Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. Hyperlipidemia is an umbrella term that refers to acquired or genetic disorders that result in high levels of lipids (fats, cholesterol, or triglycerides) circulating in the blood. This disease is usually chronic and requires ongoing medication to control blood lipid levels.

Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.

Hyperlipidemias are divided into primary and secondary subtypes. Primary hyperlipidemia is usually due to genetic causes (such as a mutation in a receptor protein), while secondary hyperlipidemia arises due to other underlying causes such as diabetes. Lipid and lipoprotein abnormalities are common in the general population and are regarded as modifiable risk factors for cardiovascular disease due to their influence on atherosclerosis. In addition, some forms may predispose to acute pancreatitis.

Broader Problems:
Diseases of metabolism
Medicine Specific diseases
Related UN Sustainable Development Goals:
GOAL 3: Good Health and Well-being
Problem Type:
E: Emanations of other problems
Date of last update
09.09.2019 – 20:53 CEST